1. Home
  2. ACET vs RBOT Comparison

ACET vs RBOT Comparison

Compare ACET & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.51

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Vicarious Surgical Inc.

RBOT

Vicarious Surgical Inc.

HOLD

Current Price

$1.98

Market Cap

17.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
RBOT
Founded
1947
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
17.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
RBOT
Price
$7.51
$1.98
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$65.33
$7.00
AVG Volume (30 Days)
161.1K
58.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.71
52 Week High
$9.05
$13.75

Technical Indicators

Market Signals
Indicator
ACET
RBOT
Relative Strength Index (RSI) 55.37 45.38
Support Level $6.54 $1.76
Resistance Level $8.46 $2.41
Average True Range (ATR) 0.47 0.20
MACD -0.00 0.03
Stochastic Oscillator 61.05 38.63

Price Performance

Historical Comparison
ACET
RBOT

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.

Share on Social Networks: